Comparing VWR Corporation (VWR) and The Competition
VWR Corporation (NASDAQ: VWR) is one of 88 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its competitors? We will compare VWR Corporation to similar companies based on the strength of its profitability, risk, earnings, dividends, analyst recommendations, valuation and institutional ownership.
Risk and Volatility
VWR Corporation has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, VWR Corporation’s competitors have a beta of 1.14, indicating that their average stock price is 14% more volatile than the S&P 500.
This is a breakdown of recent recommendations and price targets for VWR Corporation and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|VWR Corporation Competitors||181||1173||2553||90||2.64|
VWR Corporation presently has a consensus price target of $29.00, suggesting a potential downside of 12.39%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.70%. Given VWR Corporation’s competitors stronger consensus rating and higher probable upside, analysts clearly believe VWR Corporation has less favorable growth aspects than its competitors.
Valuation and Earnings
This table compares VWR Corporation and its competitors revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|VWR Corporation||$4.51 billion||$148.20 million||30.65|
|VWR Corporation Competitors||$1.08 billion||$133.13 million||104.68|
VWR Corporation has higher revenue and earnings than its competitors. VWR Corporation is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Institutional and Insider Ownership
97.5% of VWR Corporation shares are owned by institutional investors. Comparatively, 66.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 35.5% of VWR Corporation shares are owned by insiders. Comparatively, 11.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares VWR Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|VWR Corporation Competitors||-128.40%||-34.43%||-11.58%|
VWR Corporation beats its competitors on 8 of the 13 factors compared.
VWR Corporation Company Profile
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC. The Americas segment consists of operations located principally in the United States and Canada, as well as in Puerto Rico, Mexico and select countries in Central and South America, including Costa Rica, Brazil, Argentina and Chile. As of December 31, 2016, the Americas segment included 67 facilities located in eight countries. As of December 31, 2016, the EMEA-APAC segment consisted of its operations located principally in Europe, as well as in certain Asia-Pacific countries, and included 110 facilities located in 26 countries. The Company’s portfolio includes chemicals, reagents, consumables, durable products and scientific equipment and instruments.
Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with MarketBeat.com's FREE daily email newsletter.